Dose escalation with integrated boost using high-field MR-LINAC in prostate cancer patients

被引：0
|
作者：
Onal, C. [1 ]
Arslan, G. [2 ]
Yavas, C. [2 ]
Efe, E. [2 ]
Yavas, G. [2 ]
机构：
[1] Baskent Uiniv, Dept Radiat Oncol, Adana, Turkiye
[2] Baskent Univ, Dept Radiat Oncol, Ankara, Turkiye
来源：
RADIOTHERAPY AND ONCOLOGY | 2023年 / 182卷
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
PO-1854
引用
收藏
页码：S1594 / S1595
页数：2
相关论文
共 50 条
  • [21] Dosimetric validation of the couch and coil model for high-field MR-linac treatment planning
    Lynggaard, Hans
    Christiansena, Rasmus Luebeck
    Tilly, Nina
    Tilly, David
    ZEITSCHRIFT FUR MEDIZINISCHE PHYSIK, 2023, 33 (04): : 567 - 577
  • [22] An End-to-End Verification of Online Adaptation Process on a High-Field MR-Linac
    Ahunbay, E. E.
    Chen, X.
    Paulson, E. S.
    Chen, G. P.
    Li, A.
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2018, 102 (03): : S131 - S131
  • [23] Axillary lymph node boost: simultaneously integrated on CBCT-Linac or sequential on MR-Linac?
    Bouwmans, R.
    Koerkamp, M. Groot
    Van der Leij, F.
    Bol, G.
    Kotte, A.
    Houweling, A.
    RADIOTHERAPY AND ONCOLOGY, 2022, 170 : S1666 - S1668
  • [24] Two-fraction prostate radiotherapy using high field MR-linac: technique and initial experience
    Mitchell, R. A.
    Diamantopoulos, S.
    Dunlop, A.
    Alexander, S.
    Goodwin, E.
    Herbert, T.
    Jones, S.
    Mohajer, J.
    Nill, S.
    Smith, G. A.
    Westley, R.
    Oelfke, U.
    Tree, A.
    RADIOTHERAPY AND ONCOLOGY, 2022, 170 : S1460 - S1461
  • [25] Changes of volume of OARs during radiochemotherapy in a HNSCC patient treated at a high-field MR-Linac
    lo Russo, M.
    Nachbar, M.
    Moenich, D.
    Dohm, O.
    Weidner, N.
    Thorwarth, D.
    Welz, S.
    Livi, L.
    Zips, D.
    Gani, C.
    Boeke, S.
    STRAHLENTHERAPIE UND ONKOLOGIE, 2019, 195 : S127 - S127
  • [26] Commissioning Report of a High Field MR-Linac System
    Tyagi, N.
    Subashi, E.
    Scripes, P. Godoy
    Mechalakos, J.
    Souto, X. Gonzalez
    Lim, S.
    MEDICAL PHYSICS, 2020, 47 (06) : E723 - E723
  • [27] Daily prostate ADC in patients having SABR and conventional prostate cancer treatment on an MR-Linac
    Moore, C.
    Jackson, S.
    Stickley, J.
    Clough, A.
    Nelder, C.
    Chuter, R.
    Choudhury, A.
    McHugh, D.
    Dubec, M.
    RADIOTHERAPY AND ONCOLOGY, 2022, 170 : S1554 - S1555
  • [28] Opportunities and challenges in the adoption and implementation of MR-Linac for prostate cancer
    Hehakaya, C.
    Van der Voort van Zyp, J.
    Lagendijk, J.
    Grobbee, D.
    Verkooijen, H.
    Ellen, M.
    RADIOTHERAPY AND ONCOLOGY, 2020, 152 : S672 - S672
  • [29] Daily adaptive radiotherapy for patients with prostate cancer using a high field MR-linac: Initial clinical experiences and assessment of delivered doses compared to a C-arm linac
    Dunlop, Alex
    Mitchell, Adam
    Tree, Alison
    Barnes, Helen
    Bower, Lorna
    Chick, Joan
    Goodwin, Edmund
    Herbert, Trina
    Lawes, Rebekah
    McNair, Helen
    McQuaid, Dualta
    Mohajer, Jonathan
    Nilawar, Rahul
    Pathmanathan, Angela
    Smith, Gillian
    Hanson, Ian
    Nill, Simeon
    Oelfke, Uwe
    CLINICAL AND TRANSLATIONAL RADIATION ONCOLOGY, 2020, 23 : 35 - 42
  • [30] Localized prostate cancer: Dose escalation using hypofractionated simultaneous integrated boost to the tomotherapy.
    Geinitz, H.
    Geier, M.
    Gnann, J.
    Mueller, A.
    Thamm, R.
    Duma, N. M.
    Astner, S. T.
    Jacob, V.
    Busch, R.
    Molls, M.
    STRAHLENTHERAPIE UND ONKOLOGIE, 2011, 187 (01) : 73 - 73
12345